295 related articles for article (PubMed ID: 15121110)
1. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):603-7. PubMed ID: 15121110
[TBL] [Abstract][Full Text] [Related]
2. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
[TBL] [Abstract][Full Text] [Related]
4. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection.
Ghiselli R; Giacometti A; Goffi L; Cirioni O; Boccoli G; Mocchegiani F; Riva A; Scalise G; Saba V
Eur J Vasc Endovasc Surg; 2000 Dec; 20(6):508-11. PubMed ID: 11136585
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
Ghiselli R; Giacometti A; Goffi L; Cirioni O; Mocchegiani F; Orlando F; Paggi AM; Petrelli E; Scalise G; Saba V
J Surg Res; 2001 Aug; 99(2):316-20. PubMed ID: 11469904
[TBL] [Abstract][Full Text] [Related]
7. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Atahan E; Gul M; Ergun Y; Eroglu E
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
[TBL] [Abstract][Full Text] [Related]
8. Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.
Turgut H; Sacar S; Kaleli I; Sacar M; Goksin I; Toprak S; Asan A; Cevahir N; Tekin K; Baltalarli A
BMC Infect Dis; 2005 Oct; 5():91. PubMed ID: 16242027
[TBL] [Abstract][Full Text] [Related]
9. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
[TBL] [Abstract][Full Text] [Related]
11. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
[TBL] [Abstract][Full Text] [Related]
12. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.
Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
Antimicrob Agents Chemother; 2000 Dec; 44(12):3306-9. PubMed ID: 11083632
[TBL] [Abstract][Full Text] [Related]
13. Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus graft infection.
Morishima M; Marui A; Yanagi S; Nomura T; Nakajima N; Hyon SH; Ikeda T; Sakata R
Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):52-5. PubMed ID: 20360210
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of collagen silver-coated polyester and rifampin-soaked vascular grafts to resist infection from MRSA and Escherichia coli in a dog model.
Schneider F; O'Connor S; Becquemin JP
Ann Vasc Surg; 2008 Nov; 22(6):815-21. PubMed ID: 18835516
[TBL] [Abstract][Full Text] [Related]
15. [Experimental examination concerning the efficacy of silver-coated Dacron prostheses in vascular graft infections following subcutaneous implantation in a standardized infection model].
Hernández-Richter T; Wittmann F; Mayr S; Schmitt-Sody M; Blasenbreu S; Wichmann M; Heiss MM; Schardey HM; Angele MK
Zentralbl Chir; 2003 Mar; 128(3):244-9. PubMed ID: 12739511
[TBL] [Abstract][Full Text] [Related]
16. Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Kamysz W; Del Prete MS; Lukasiak J; Scalise G; Saba V
J Vasc Surg; 2002 Nov; 36(5):1027-30. PubMed ID: 12422090
[TBL] [Abstract][Full Text] [Related]
17. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci.
Domenico P; Gurzenda E; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Korem M; Saba V; Scalise G; Balaban N
Peptides; 2004 Dec; 25(12):2047-53. PubMed ID: 15572191
[TBL] [Abstract][Full Text] [Related]
18. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.
Yasim A; Gul M; Ciralik H; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):425-30. PubMed ID: 16725356
[TBL] [Abstract][Full Text] [Related]
19. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
Balaban N; Giacometti A; Cirioni O; Gov Y; Ghiselli R; Mocchegiani F; Viticchi C; Del Prete MS; Saba V; Scalise G; Dell'Acqua G
J Infect Dis; 2003 Feb; 187(4):625-30. PubMed ID: 12599079
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection.
Cirioni O; Mocchegiani F; Ghiselli R; Silvestri C; Gabrielli E; Marchionni E; Orlando F; Nicolini D; Risaliti A; Giacometti A
Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):817-22. PubMed ID: 20869272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
